Momentum Biotechnologies and Axxam announce collaboration to provide unique drug discovery solutions
- 15 November 2023
We have joined forces with Momentum Biotechnologies to power drug discovery solutions for the biotech and pharmaceutical industries.
Through this partnership our extensive chemical diversity library is now accessible for high-throughput screening via Momentum’s cutting-edge mass spectrometry-based platforms.
Together, we’re advancing innovation in hit identification and reinforcing the first stages of drug discovery.